Practical alternatives to chronic caloric restriction for optimizing vascular function with ageing

Journal of Physiology

Volumn 594, Issue 24, 2016, Pages 7177-7195

  Martens, Christopher R ^a   Seals, Douglas R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

arterial stiffness; CR mimetics; endothelial dysfunction; energy sensing; intermittent fasting

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITRIC OXIDE; SIRTUIN;

AGING; ARTERIAL STIFFNESS; AUTOPHAGY; BIOAVAILABILITY; BODY WEIGHT; CALORIC RESTRICTION; CARDIOVASCULAR FUNCTION; DIET RESTRICTION; ENDOTHELIAL DYSFUNCTION; ENERGY; EXERCISE; HOMEOSTASIS; HUMAN; LIFESTYLE; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; CALORIC RESTRICTION; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; ENDOTHELIUM, VASCULAR; HUMANS; VASCULAR STIFFNESS;

EID: 85003819827     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP272348     Document Type: Review

References (126)

1. Ahmet I, Wan RQ, Mattson MP, Lakatta EG & Talan M (2005). Cardioprotection by intermittent fasting in rats. Circulation 112, 3115–3121.
2. Bai B, Vanhoutte PM & Wang Y (2014). Loss-of-SIRT1 function during vascular ageing: Hyperphosphorylation mediated by cyclin-dependent kinase 5. Trends Cardiovasc Med 24, 81–84.
3. Baron S, Bedarida T, Cottart C, Vibert F, Vessieres E, Ayer A, Henrion D, Hommeril B, Paul J, Renault G, Saubamea B, Beaudeux J, Procaccio V & Nivet-Antoine V (2014). Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice. J Gerontol A Biol Sci Med Sci 69, 260–269.
4. Baur JA (2010). Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 131, 261–269.
5. Berkowitz DE, White R, Li DC, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC & Hare JM (2003). Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108, 2000–2006.
6. + precursor vitamins in human nutrition. Annu Rev Nutr 28, 115–130.
7. Boutant M, Kulkarni SS, Joffraud M, Raymond F, Metairon S, Descombes P & Canto C (2016). SIRT1 gain of function does not mimic or enhance the adaptations to intermittent fasting. Cell Rep 14, 2068–2075.
8. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti PS, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB & Longo VD (2015). A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab 22, 86–99.
9. Brook RD (2006). Obesity, weight loss, and vascular function. Endocrine 29, 21–25.
10. Canto C & Auwerx J (2011). Calorie restriction: Is AMPK a key sensor and effector? Physiology 26, 214–224.
11. + precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15, 838–847.
12. Carrizzo A, Puca A, Damato A, Marino M, Franco E, Pompeo F, Traficante A, Civitillo F, Santini L, Trimarco V & Vecchione C (2013). Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension 62, 359–366.
13. Chaix A, Zarrinpar A, Miu P & Panda S (2014). Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 20, 991–1005.
14. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, de Montellano PRO & Kemp BE (1999). AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443, 285–289.
15. Chung KW, Kim DH, Park MH, Choi YJ, Kim ND, Lee J, Yu BP & Chung HY (2013). Recent advances in calorie restriction research on aging. Exp Gerontol 48, 1049–1053.
16. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM & Stern DM (1998). Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527–3561.
17. Crandall JP, Oram V, Rescu GT, Reid M, Kishore P, Hawkins M, Cohen HW & Barzilai N (2012). Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67, 1307–1312.
18. Cruzen C & Colman RJ (2009). Effects of caloric restriction on cardiovascular aging in non-human primates and humans. Clin Geriatr Med 25, 733–743.
19. Csiszar A, Labinskyy N, Jimenez R, Pinto JT, Ballabh P, Losonczy G, Pearson KJ, de Cabo R & Ungvari Z (2009). Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1. Mech Ageing Dev 130, 518–527.
20. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A & Ungvari Z (2006). Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells: Role of NF-κB inhibition. Am J Physiol Heart Circ Physiol 291, H1694–H1699.
21. da Luz PL, Tanaka L, Brum PC, Martins Dourado PM, Favarato D, Krieger JE & Laurindo FRM (2012). Red wine and equivalent oral pharmacological doses of resveratrol delay vascular aging but do not extend life span in rats. Atherosclerosis 224, 136–142.
22. de Picciotto NE, Gano LB, Johnson LC, Martens CR, Sindler AL, Mills KF, Imai S & Seals DR (2016). Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell 15, 522–530.
23. Dengo AL, Dennis EA, Orr JS, Marinik EL, Ehrlich E, Davy BM & Davy KP (2010). Arterial destiffening with weight loss in overweight and obese middle-aged and older adults. Hypertension 55, 855–861.
24. DeSouza CA, Shapiro LF, Clevenger CM, Dinenno FA, Monahan KD, Tanaka H & Seals DR (2000). Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102, 1351–1357.
25. Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA & Seals DR (2011). SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 589, 4545–4554.
26. Donato AJ, Morgan RG, Walker AE & Lesniewski LA (2015). Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol 89, 122–135.
27. Donato AJ, Walker AE, Magerko KA, Bramwell RC, Black AD, Henson GD, Lawson BR, Lesniewski LA & Seals DR (2013). Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell 12, 772–783.
28. Eskurza I, Myerburgh LA, Kahn ZD & Seals DR (2005). Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J Physiol 568, 1057–1065.
29. Faris MAE, Hussein RN, Al-Kurd RA, Al-Fararjeh MA, Bustanji YK & Mohammad MK (2012b). Impact of Ramadan intermittent fasting on oxidative stress measured by urinary 15-f(2t)-isoprostane. J Nutr Metab 2012, 802924.
30. Faris ME, Kacimi S, Al-Kurd RA, Fararjeh MA, Bustanji YK, Mohammad MK & Salem ML (2012a). Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res 32, 947–955.
31. Fisslthaler B & Fleming I (2009). Activation and signalling by the AMP-activated protein kinase in endothelial cells. Circ Res 105, 114–127.
32. Fleenor BS (2013). Large elastic artery stiffness with aging: Novel translational mechanisms and interventions. Aging Dis 4, 76–83.
33. Fleenor BS, Marshall KD, Durrant JR, Lesniewski LA & Seals DR (2010). Arterial stiffening with ageing is associated with transforming growth factor-beta 1-related changes in adventitial collagen: Reversal by aerobic exercise. J Physiol 588, 3971–3982.
34. Fleenor BS, Seals DR, Zigler ML & Sindler AL (2012). Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell 11, 269–276.
35. Gano LB, Donato AJ, Pasha HM, Hearon CM Jr, Sindler AL & Seals DR (2014). The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice. Am J Physiol Heart Circ Physiol 307, H1754–H1763.
36. Gliemann L, Schmidt JF, Olesen J, Bienso RS, Peronard SL, Grandjean SU, Mortensen SP, Nyberg M, Bangsbo J, Pilegaard H & Hellsten Y (2013). Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol 591, 5047–5059.
37. + induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624–1638.
38. Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, Wang J, Sastre M, Ono K, Sauve AA & Pasinetti GM (2013). Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in alzheimer's mouse models. Neurobiol Aging 34, 1581–1588.
39. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A & Howell A (2011). The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: A randomized trial in young overweight women. Int J Obes 35, 714–727.
40. Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, Leblanc M, Chaix A, Joens M, Fitzpatrick JAJ, Ellisman MH & Panda S (2012). Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab 15, 848–860.
41. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B & Sinclair DA (2003). Small molecule activators of sirtuins extend saccharomyces cerevisiae lifespan. Nature 425, 191–196.
42. Hubbard BP & Sinclair DA (2014). Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci 35, 146–154.
43. Imai S (2009). The NAD world: A new systemic regulatory network for metabolism and aging-Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 53, 65–74.
44. Imai S (2010). A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol Res 62, 42–47.
45. Ingram DK, Zhu M, Mamczarz J, Zou SG, Lane MA, Roth GS & deCabo R (2006). Calorie restriction mimetics: An emerging research field. Aging Cell 5, 97–108.
46. Jefferson ME, Nicklas BJ, Chmelo EA, Crotts CI, Shaltout HA, Diz DI, Marsh AP & Brinkley TE (2016). Effects of resistance training with and without caloric restriction on arterial stiffness in overweight and obese older adults. Am J Hypertens 29, 494–500.
47. Jia K & Levine B (2007). Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 3, 597–599.
48. Johnson SC, Rabinovitch PS & Kaeberlein M (2013). mTOR is a key modulator of ageing and age-related disease. Nature 493, 338–345.
49. Kaplon RE, Hill SD, Bispham NZ, Santos-Parker JR, Nowlan MJ, Snyder LL, Chonchol M, LaRocca TJ, McQueen MB & Seals DR (2016). Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-aged and older adults. Aging 8, 1167–1183.
50. Kim H, Park K, Yoo E, Kim Y, Kim Y, Kim H, Kim HT, Park J, Lee K, Jang WG, Kim J, Kim B & Lee I (2007). Effects of PGC-1α on TNF-α-induced MCP-1 and VCAM-1 expression and NF-κB activation in human aortic smooth muscle and endothelial cells. Antioxid Redox Signal 9, 301–307.
51. Kroeger CM, Klempel MC, Bhutani S, Trepanowski JF, Tangney CC & Varady KA (2012). Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: Relationship to adipokine modulations. Nutr Metab 9, 98.
52. Kuhla A, Lange S, Holzmann C, Maass F, Petersen J, Vollmar B & Wree A (2013). Lifelong caloric restriction increases working memory in mice. Plos One 8, e68778.
53. Lakatta EG & Levy D (2003). Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises part I: Aging arteries: A "set up" for vascular disease. Circulation 107, 139–146.
54. Lamming DW, Ye L, Sabatini DM & Baur JA (2013). Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest 123, 980–989.
55. LaRocca TJ, Gioscia-Ryan RA, Hearon CM Jr & Seals DR (2013). The autophagy enhancer spermidine reverses arterial aging. Mech Ageing Dev 134, 314–320.
56. LaRocca TJ, Henson GD, Thorburn A, Sindler AL, Pierce GL & Seals DR (2012). Translational evidence that impaired autophagy contributes to arterial ageing. J Physiol 590, 3305–3316.
57. Lesniewski LA, Durrant JR, Connell ML, Folian BJ, Donato AJ & Seals DR (2011). Salicylate treatment improves age-associated vascular endothelial dysfunction: Potential role of nuclear factor κB and forkhead box O phosphorylation. J Gerontol A Biol Sci Med Sci 66, 409–418.
58. Lesniewski LA, Seals DR, Walker AE, Henson GD, Blimline MW, Bosshardt GC, LaRocca TJ, Lawson BR, Zigler MC & Donato AJ (2016). Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient sensing, cell cycle and senescence pathways. Aging Cell (in press; doi: 10.1111/acel.12524).
59. Lesniewski LA, Zigler MC, Durrant JR, Donato AJ & Seals DR (2012). Sustained activation of AMPK ameliorates age-associated vascular endothelial dysfunction via a nitric oxide-independent mechanism. Mech Ageing Dev 133, 368–371.
60. Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng C, Madia F, Fontana L, Mirisola MG, Guevara-Aguirre J, Wan J, Passarino G, Kennedy BK, Wei M, Cohen P, Crimmins EM & Longo VD (2014). Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab 19, 407–417.
61. Lin L, Park S & Lakatta EG (2009). RAGE signaling in inflammation and arterial aging. Front Biosci 14, 1403–1413.
62. Liu M, Wilk SA, Wang A, Zhou L, Wang R, Ogawa W, Deng C, Dong LQ & Liu F (2010). Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J Biol Chem 285, 36387–36394.
63. Longo VD & Mattson MP (2014). Fasting: Molecular mechanisms and clinical applications. Cell Metab 19, 181–192.
64. Longo VD & Panda S (2016). Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab 23, 1048–1059.
65. Luscher TF & Barton M (1997). Biology of the endothelium. Clin Cardiol 20 (Suppl II), II-3-II-10.
66. Mager DE, Wan R, Brown M, Cheng A, Wareski P, Abernethy DR & Mattson MP (2006). Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J 20, 631–637.
67. Mattagajasingh I, Kim C, Naqvi A, Yamamori T, Hoffman TA, Jung S, DeRicco J, Kasuno K & Irani K (2007). SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 104, 14855–14860.
68. Mattison JA, Wang M, Bernier M, Zhang J, Park S, Maudsley S, An SS, Santhanam L, Martin B, Faulkner S, Morrell C, Baur JA, Peshkin L, Sosnowska D, Csiszar A, Herbert RL, Tilmont EM, Ungvari Z, Pearson KJ, Lakatta EG & de Cabo R (2014). Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates. Cell Metab 20, 183–190.
69. Mattson MP, Allison DB, Fontana L, Harvie M, Longo VD, Malaisse WJ, Mosley M, Notterpek L, Ravussin E, Scheer FAJL, Seyfried TN, Varady KA & Panda S (2014). Meal frequency and timing in health and disease. Proc Natl Acad Sci USA 111, 16647–16653.
70. Mattson MP & Wan RQ (2005). Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 16, 129–137.
71. Mazidi M, Rezaie P, Chaudhri O, Karimi E & Nematy M (2015). The effect of Ramadan fasting on cardiometabolic risk factors and anthropometrics parameters: A systematic review. Pak J Med Sci 31, 1250–1255.
72. McCarty MF (2014). AMPK activation-protean potential for boosting healthspan. Age 36, 641–663.
73. Miller SL & Wolfe RR (2008). The danger of weight loss in the elderly. J Nutr Health Aging 12, 487–491.
74. Ming X, Montani J & Yang Z (2012). Perspectives of targeting mTORC1-S6K1 in cardiovascular aging. Front Physiol 3, 5.
75. Moreau KL, Donato AJ, Seals DR, DeSouza CA & Tanaka H (2003). Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women. Cardiovasc Res 57, 861–868.
76. Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, Criollo A, Galluzzi L, Malik SA, Vitale I, Michaud M, Madeo F, Tavernarakis N & Kroemer G (2010). Caloric restriction and resveratrol promote longevity through the sirtuin-1-dependent induction of autophagy. Cell Death Dis 1, e10.
77. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres J, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee & Stroke Statistics Subcommittee (2016). Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 133, e38–e360.
78. Nakamaru Y, Vuppusetty C, Wada H, Milne JC, Ito M, Rossios C, Elliot M, Hogg J, Kharitonov S, Goto H, Bemis JE, Elliott P, Barnes PJ & Ito K (2009). A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 23, 2810–2819.
79. Nematy M, Alinezhad-Namaghi M, Rashed MM, Mozhdehifard M, Sajjadi SS, Akhlaghi S, Sabery M, Mohajeri SAR, Shalaey N, Moohebati M & Norouzy A (2012). Effects of Ramadan fasting on cardiovascular risk factors: A prospective observational study. Nutr J 11, 69.
80. Normandin E, Houston DK & Nicklas BJ (2015). Caloric restriction for treatment of geriatric obesity: Do the benefits outweigh the risks? Curr Nutr Rep 4, 143–155.
81. Olmos Y, Sanchez-Gomez FJ, Wild B, Garcia-Quintans N, Cabezudo S, Lamas S & Monsalve M (2013). SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex. Antioxid Redox Sig 19, 1507–1521.
82. Olshansky SJ, Goldman DP, Zheng Y & Rowe JW (2009). Aging in America in the twenty-first century: Demographic forecasts from the MacArthur Foundation Research Network on an aging society. Milbank Q 87, 842–862.
83. Ota H, Eto M, Kano MR, Ogawa S, Iijima K, Akishita M & Ouchi Y (2008). Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler Thromb Vasc Biol 28, 1634–1639.
84. Palmer RMJ, Ashton DS & Moncada S (1988). Vascular endothelial-cells synthesize nitric-oxide from L-arginine. Nature 333, 664–666.
85. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA & de Cabo R (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8, 157–168.
86. Pierce GL, Beske SD, Lawson BR, Southall KL, Benay FJ, Donato AJ & Seals DR (2008). Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension 52, 72–79.
87. Pierce GL, Lesniewski LA, Lawson BR, Beske SD & Seals DR (2009). Nuclear factor-κB activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 119, 1284–1292.
88. Potente M & Dimmeler S (2008). NO targets SIRT1: A novel signaling network in endothelial senescence. Arterioscler Thromb Vasc Biol 28, 1577–1579.
89. Rajapakse AG, Yepuri G, Carvas JM, Stein S, Matter CM, Scerri I, Ruffieux J, Montani J, Ming X & Yang Z (2011). Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: Inhibition by resveratrol. Plos One 6, e19237.
90. Razzak RLA, Abu-Hozaifa BM, Bamosa AO & Ali NM (2011). Assessment of enhanced endothelium-dependent vasodilation by intermittent fasting in wistar albino rats. Indian J Physiol Pharmacol 55, 336–42.
91. Reineke DC, Mueller-Schweinitzer E, Winkler B, Kunz D, Konerding MA, Grussenmeyer T, Carrel TP, Eckstein FS & Grapow MTR (2015). Rapamycin impairs endothelial cell function in human internal thoracic arteries. Eur J Med Res 20, 59.
92. Rippe C, Lesniewski LA, Connell ML, LaRocca TJ, Donato AJ & Seals DR (2010). Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell 9, 304–312.
93. Rothschild J, Hoddy KK, Jambazian P & Varady KA (2014). Time-restricted feeding and risk of metabolic disease: A review of human and animal studies. Nutr Rev 72, 308–318.
94. Rubinsztein DC, Marino G & Kroemer G (2011). Autophagy and aging. Cell 146, 682–695.
95. Safar ME, Levy BI & Struijker-Boudier H (2003). Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107, 2864–2869.
96. Santos J, Leitao-Correia F, Sousa MJ & Leao C (2016). Dietary restriction and nutrient balance in aging. Oxid Med Cell Longev 2016, 4010357.
97. Santos-Parker JR & Kaplon RE (2014). Supplementing exercise: Translational considerations for nutraceutical and lifestyle interventions. J Physiol 592, 427–428.
98. Seals DR (2014). Edward F. Adolph Distinguished Lecture: The remarkable anti-aging effects of aerobic exercise on systemic arteries. J Appl Physiol 117, 425–439.
99. Seals DR, DeSouza CA, Donato AJ & Tanaka H (2008). Habitual exercise and arterial aging. J Appl Physiol 105, 1323–1332.
100. Seals DR, Jablonski KL & Donato AJ (2011). Aging and vascular endothelial function in humans. Clin Sci 120, 357–375.
101. Seals DR & Melov S (2014). Translational geroscience: Emphasizing function to achieve optimal longevity. Aging 6, 718–730.
102. Singer J, Trollor JN, Baune BT, Sachdev PS & Smith E (2014). Arterial stiffness, the brain and cognition: A systematic review. Ageing Res Rev 15, 16–27.
103. Tajbakhsh N & Sokoya EM (2012). Regulation of cerebral vascular function by sirtuin 1. Microcirculation 19, 336–342.
104. Tanaka H, DeSouza CA & Seals DR (1998). Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 18, 127–132.
105. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA & Seals DR (2000). Aging, habitual exercise, and dynamic arterial compliance. Circulation 102, 1270–1275.
106. Ungvari Z, Parrado-Fernandez C, Csiszar A & de Cabo R (2008). Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circ Res 102, 519–528.
107. Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, Hoddy KK & Calvo Y (2013). Alternate day fasting for weight loss in normal weight and overweight subjects: A randomized controlled trial. Nutr J 12, 146.
108. Varady KA & Hellerstein MK (2007). Alternate-day fasting and chronic disease prevention: A review of human and animal trials. Am J Clin Nutr 86, 7–13.
109. Villareal DT, Fontana L, Das SK, Redman L, Smith SR, Saltzman E, Bales C, Rochon J, Pieper C, Huang M, Lewis M, Schwartz AV & CALERIE Study Group (2016). Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: A randomized clinical trial. J Bone Miner Res 31, 40–51.
110. Wahl M & Schilling L (1993). Regulation of cerebral blood-flow: a brief review. Acta Neurochir 59, 3–10.
111. Walker AE, Henson GD, Reihl KD, Nielson EI, Morgan RG, Lesniewski LA & Donato AJ (2014a). Beneficial effects of lifelong caloric restriction on endothelial function are greater in conduit arteries compared to cerebral resistance arteries. Age 36, 559–569.
112. Walker AE, Kaplon RE, Pierce GL, Nowlan MJ & Seals DR (2014b). Prevention of age-related endothelial dysfunction by habitual aerobic exercise in healthy humans: Possible role of nuclear factor κB. Clin Sci 127, 645–654.
113. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K & Forstermann U (2002). Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106, 1652–1658.
114. Wasselin T, Zahn S, Le Maho Y, Van Dorsselaer A, Raclot T & Bertile F (2014). Exacerbated oxidative stress in the fasting liver according to fuel partitioning. Proteomics 14, 1905–1921.
115. Waters DL, Ward AL & Villareal DT (2013). Weight loss in obese adults 65 years and older: A review of the controversy. Exp Gerontol 48, 1054–1061.
116. Witte AV, Fobker M, Gellner R, Knecht S & Floeel A (2009). Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA 106, 1255–1260.
117. Wong RHX, Berry NM, Coates AM, Buckley JD, Bryan J, Kunz I & Howe PRC (2013). Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens 31, 1819–1827.
118. Wong RHX, Howe PRC, Buckley JD, Coates AM, Kunz I & Berry NM (2011). Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 21, 851–856.
119. Wu J, Wang Z, Hsieh T, Bruder J, Zou J & Huang Y (2001). Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int J Mol Med 8, 3–17.
120. Xia N, Strand S, Schlufter F, Siuda D, Reifenberg G, Kleinert H, Foerstermann U & Li H (2013). Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. Nitric Oxide Biol Chem 32, 29–35.
121. Xu S, Cai Y & Wei Y (2014). mTOR signaling from cellular senescence to organismal aging. Aging Dis 5, 263–273.
122. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME & Lindsey ML (2013). Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology 28, 391–403.
123. Yepuri G, Velagapudi S, Xiong Y, Rajapakse AG, Montani J, Ming X & Yang Z (2012). Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging. Aging Cell 11, 1005–1016.
124. Zanetti M, Cappellari GG, Burekovic I, Barazzoni R, Stebel M & Guarnieri G (2010). Caloric restriction improves endothelial dysfunction during vascular aging effects on nitric oxide synthase isoforms and oxidative stress in rat aorta. Exp Gerontol 45, 848–855.
125. Zhou R, Vendrov AE, Tchivilev I, Niu X, Molnar KC, Rojas M, Carter JD, Tong H, Stouffer GA, Madamanchi NR & Runge MS (2012). Mitochondrial oxidative stress in aortic stiffening with age the role of smooth muscle cell function. Arterioscler Thromb Vasc Biol 32, 745–755.
126. Zoncu R, Efeyan A & Sabatini DM (2011). mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21–35.